statistiche ricercatore

Continente	#
EU - Europa	1.928
NA - Nord America	963
AS - Asia	603
SA - Sud America	100
AF - Africa	15
OC - Oceania	7
Continente sconosciuto - Info sul continente non disponibili	2
Totale	3.618

Nazione	#
DE - Germania	1.213
US - Stati Uniti d'America	941
CN - Cina	229
SG - Singapore	226
SE - Svezia	146
IT - Italia	112
GB - Regno Unito	108
UA - Ucraina	97
BR - Brasile	83
FR - Francia	79
PL - Polonia	43
IN - India	33
IE - Irlanda	30
RU - Federazione Russa	27
VN - Vietnam	26
FI - Finlandia	23
ID - Indonesia	17
TR - Turchia	17
CA - Canada	12
BE - Belgio	11
ES - Italia	8
NL - Olanda	8
AR - Argentina	7
IR - Iran	7
AU - Australia	6
HK - Hong Kong	6
RO - Romania	6
ZA - Sudafrica	6
KR - Corea	5
MX - Messico	5
PK - Pakistan	5
BD - Bangladesh	4
EG - Egitto	4
UZ - Uzbekistan	4
DZ - Algeria	3
EC - Ecuador	3
IQ - Iraq	3
JP - Giappone	3
PH - Filippine	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
AZ - Azerbaigian	2
BS - Bahamas	2
CH - Svizzera	2
CO - Colombia	2
IL - Israele	2
LT - Lituania	2
PT - Portogallo	2
PY - Paraguay	2
SA - Arabia Saudita	2
VE - Venezuela	2
A1 - Anonimo	1
AL - Albania	1
AM - Armenia	1
AO - Angola	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EU - Europa	1
GE - Georgia	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
LB - Libano	1
LK - Sri Lanka	1
LU - Lussemburgo	1
LV - Lettonia	1
MY - Malesia	1
NO - Norvegia	1
NP - Nepal	1
NZ - Nuova Zelanda	1
OM - Oman	1
SK - Slovacchia (Repubblica Slovacca)	1
UY - Uruguay	1
Totale	3.618

Nome	#
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth	489
The Role of Methane in Intestinal Diseases.	414
Small intestinal bacterial overgrowth recurrence after antibiotic therapy	403
Bacillus clausii as a treatment of small intestinal bacterial overgrowth.	275
ag)Association between hypothyroidism and small intestinal bacterial overgrowth	246
The role of small intestinal bacterial overgrowth in Parkinson's disease	228
-High prevalence of celiac disease in patients with lactose intolerance	212
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?	209
Small intestinal bacterial overgrowth and intestinal permeability.	190
Rifaximin pharmacology and clinical implications.	156
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth	152
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.	142
Gut microbiota and obesity.	142
ag) Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.	137
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet.	136
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.	106
Totale	3.637

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	126	0	0	0	0	0	11	20	12	23	11	45	4
2021/2022	210	6	21	3	11	24	8	3	40	8	8	27	51
2022/2023	400	54	57	38	75	17	46	25	32	45	3	5	3
2023/2024	166	7	51	2	2	3	27	2	19	1	9	30	13
2024/2025	297	7	11	27	4	34	14	1	23	39	22	57	58
2025/2026	429	134	26	34	72	155	8	0	0	0	0	0	0
Totale													3.637

IRIS UniCatt